Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis
Osama Mohamad(The University of Texas MD Anderson Cancer Center), Mohamed Shelan(University of Bern), Thomas Zilli(University of Geneva), Andrew Loblaw(Sunnybrook Health Science Centre), Matthias Gückenberger(University Hospital of Zurich), Vedang Murthy(Homi Bhabha National Institute), Daniel M. Aebersold(University of Bern), Constantinos Zamboglou(University Hospitals of Cleveland)
International Journal of Radiation Oncology*Biology*Physics
October 18, 2023
Cited by 13
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646